Skip to main content
Microbiology Spectrum logoLink to Microbiology Spectrum
. 2019 Jan 18;7(1):10.1128/microbiolspec.gpp3-0051-2018. doi: 10.1128/microbiolspec.gpp3-0051-2018

The Biology of Streptococcus mutans

JA Lemos 1, SR Palmer 2, L Zeng 3, ZT Wen 4, JK Kajfasz 5, IA Freires 6, J Abranches 7, LJ Brady 8
Editors: Vincent A Fischetti9, Richard P Novick10, Joseph J Ferretti11, Daniel A Portnoy12, Miriam Braunstein13, Julian I Rood14
PMCID: PMC6615571  NIHMSID: NIHMS1002329  PMID: 30657107

ABSTRACT

As a major etiological agent of human dental caries, Streptococcus mutans resides primarily in biofilms that form on the tooth surfaces, also known as dental plaque. In addition to caries, S. mutans is responsible for cases of infective endocarditis with a subset of strains being indirectly implicated with the onset of additional extraoral pathologies. During the past 4 decades, functional studies of S. mutans have focused on understanding the molecular mechanisms the organism employs to form robust biofilms on tooth surfaces, to rapidly metabolize a wide variety of carbohydrates obtained from the host diet, and to survive numerous (and frequent) environmental challenges encountered in oral biofilms. In these areas of research, S. mutans has served as a model organism for ground-breaking new discoveries that have, at times, challenged long-standing dogmas based on bacterial paradigms such as Escherichia coli and Bacillus subtilis. In addition to sections dedicated to carbohydrate metabolism, biofilm formation, and stress responses, this article discusses newer developments in S. mutans biology research, namely, how S. mutans interspecies and cross-kingdom interactions dictate the development and pathogenic potential of oral biofilms and how next-generation sequencing technologies have led to a much better understanding of the physiology and diversity of S. mutans as a species.


In 1924, J. Clarke isolated an organism from carious lesions and called it Streptococcus mutans, because he thought the oval-shaped cells observed were mutant forms of streptococci (1). However, it was in the late 1950s when S. mutans gained widespread attention within the scientific community, and by the mid-1960s, clinical and animal-based laboratory studies depicted S. mutans as an important etiologic agent in dental caries (2). The natural habitat of S. mutans is the human oral cavity, more specifically, the dental plaque, a multispecies biofilm formed on hard surfaces of the tooth. It has been largely accepted that the cariogenic potential of S. mutans resides in three core attributes: (i) the ability to synthesize large quantities of extracellular polymers of glucan from sucrose that aid in the permanent colonization of hard surfaces and in the development of the extracellular polymeric matrix in situ, (ii) the ability to transport and metabolize a wide range of carbohydrates into organic acids (acidogenicity), and (iii) the ability to thrive under environmental stress conditions, particularly low pH (aciduricity) (3). While S. mutans does not act alone in the development of dental caries, studies from several laboratories have convincingly demonstrated that S. mutans can alter the local environment by forming an extracellular polysaccharide (EPS)-rich and low-pH milieu, thereby creating a favorable niche for other acidogenic and aciduric species to thrive. As a human pathogen, S. mutans is also implicated in subacute bacterial endocarditis, a life-threatening inflammation of heart valves, while a subset of strains has been linked to other extraoral pathologies such as cerebral microbleeds, IgA nephropathy, and atherosclerosis.

Strains of S. mutans can be classified into four serological groups (c, e, f, and k) based on the composition of cell-surface rhamnose-glucose polysaccharide, with ∼75% of strains isolated from dental plaque belonging to serotype c, ∼20% to serotype e, and the remaining 5% classified as serotypes f or k (4). While biochemical and genetic approaches to dissect the biology of S. mutans have been used for at least the past 4 decades, the publication of the complete genome sequence of the S. mutans strain UA159 in 2001 (5) dramatically changed the landscape, and today, S. mutans is one of the best-characterized Gram-positive pathogens. In this article, we highlight some of the key studies that have led to our current understanding of S. mutans genetics, physiology, and virulence. For a historical perspective and complete survey of the field, we direct the reader to the review articles in references 2, 3, and 69.

GENETIC AND PHENOTYPIC HETEROGENEITY

The first S. mutans genome sequenced (serotype c strain UA159) was found to contain ∼2.0 Mb of DNA and to encode approximately 2,000 genes (5). As the cost of next-generation sequencing technologies has gone down, genomes from dozens of S. mutans strains have been sequenced and assembled and are now available on public databases such as the NCBI (www.ncbi.nlm.nih.gov/assembly/?term=streptococcus+mutans). This influx of genome sequences has led to an increase in comparative genomic studies focused on S. mutans (1013). One of the first such studies was based on the shotgun genome sequence from 57 geographically diverse S. mutans clinical isolates. This study concluded that the S. mutans pan-genome contains a minimum of ∼3,300 possible genes and has a core genome (genes that are common to all strains) of 1,490 genes (14). This means that in any one S. mutans isolate, ∼500 genes could be distinct from any other strain, perhaps significantly influencing virulence potential or fitness. The same group, using population demographic analysis based on single nucleotide polymorphisms of the core genes, determined that a large expansion took place in the S. mutans population between 3,000 and 10,000 years ago, which coincided with the advent of human agriculture and increased consumption of carbohydrates in the human host diet (14). This study also identified 73 unique core genes that are found only in S. mutans and not in its closest relatives, many of which are involved in carbohydrate metabolism and acid resistance (14). In a follow-up study, Palmer et al. (15) characterized 15 of the most genetically diverse isolates of the 57 strains sequenced by Cornejo et al. (14) and found great variation in the phenotypes directly related to virulence, including the ability to form biofilm in the presence of sucrose and the ability to tolerate low pH and oxidative stresses, suggesting that not all strains of S. mutans are equally virulent and providing a rational explanation for why attempts to correlate the carriage of certain genotypes of S. mutans with the incidence of dental caries has proven so difficult (10, 1618).

Work to characterize the unique core and noncore genes is ongoing and will likely lead to a greater understanding of the physiology and diversity of S. mutans as a species. For example, one of the unique core hypothetical genes, SMu.1147, which encodes a small peptide, was found to regulate genetic competence and other traits of general importance to S. mutans virulence (19). In contrast, efforts to characterize the noncore genes indicate that they likely provide a competitive advantage under particular circumstances. Such is the case for a galactose-specific phosphotransferase system (PTS) transporter found in several strains (20). Among the many noncore genes of S. mutans identified in recent years, those encoding the collagen-binding proteins (CBPs) Cnm and Cbm were shown to confer adhesion to collagen and laminin, invasion of endothelial and epithelial cells, and virulence in the Galleria mellonella invertebrate model (21, 22) as well as in rabbit and rat models of infective endocarditis (23, 24). Epidemiological studies indicate that cnm is present in approximately 15% of S. mutans isolates, whereas cbm is rarely found (∼2%) (21, 22). Genes encoding CBPs have an uneven distribution among the different serotypes and are found at higher frequency among serotype e, f, and k strains but are rarely present in serotype c strains (25). Notably, CBP+ S. mutans strains are more frequently isolated from dental plaque of individuals with bacteremia and infective endocarditis, suggesting a correlation between the production of these adhesins and systemic infections (26). Interestingly, the presence of cnm in S. mutans strains isolated from saliva has been linked to IgA nephropathy, cerebral microbleeds, and cognitive impairment (27, 28). Finally, animal and clinical studies have suggested an association of CBPs in caries risk and severity (27, 29, 30).

CARBOHYDRATE METABOLISM

As a lactic acid bacterium, S. mutans relies exclusively on glycolysis for energy production (Fig. 1). A signature characteristic of this organism is its ability to metabolize a large variety of carbohydrates. The genome of the UA159 type strain encodes 14 phosphoenolpyruvate-dependent sugar:PTSs with specificities for various mono- and disaccharides, as well as two ATP-binding cassette (ABC) transporters involved primarily in internalizing oligosaccharides (5). Sucrose is a β2,1-linked disaccharide composed of glucose and fructose that has proven, for a number of reasons, to be the most cariogenic of all carbohydrates. S. mutans has evolved multiple pathways to catabolize sucrose for acid production (31), and several glycosyltransferase enzymes (Gtfs) convert sucrose into a glue-like extracellular polymer glucan that promotes the buildup of biofilms by way of cellular attachment to dental surfaces and other oral microorganisms (7). As discussed in more detail below, recent multispecies modeling studies have confirmed the unique roles of Gtfs in the formation of a heterogeneous, diffusion-limiting, low-pH matrix that is conducive to both dental demineralization and the eventual dominance by acid-tolerant species (7, 32).

FIGURE 1.

FIGURE 1

Carbohydrate metabolism in S. mutans. While S. mutans can metabolize a large variety of carbohydrates, the figure shows the metabolism of most common dietary sugars (fructose, glucose, and sucrose). Sucrose is a β2,1-linked disaccharide composed of glucose and fructose that has proven to be the most cariogenic of all carbohydrates. In the extracellular environment, sucrose is a substrate of glucosyltransferase (GTF) and fructosyltransferase (FTF) enzymes, which catalyze the production of glucans and fructans, respectively. The formation of glucans plays a key role in virulence, because they contribute to biofilm buildup by forming a glue-like polysaccharide matrix. Fructans serve as short-term extracellular carbohydrate sources and are degraded by the fructanase enzyme FruA, yielding fructose, which can be internalized for energy production. Glucans are susceptible to the action of an extracellular dextranase, DexA, which breaks down the α1,6-linkages, thereby yielding oligosaccharides (e.g., maltodextrans). After being transported into the cell, oligosaccharides are degraded into monosaccharides by the action of the DexB glucosidase. Oligosaccharides are primarily transported into the cells by ATP-binding cassette (ABC) transporters (e.g., Msm and MalXFGK transport systems), whereas monosaccharides (e.g., glucose and fructose) and disaccharides (e.g., sucrose) are predominantly taken up by the phosphoenolpyruvate:sugar PTS. In S. mutans, multiple PTSs can transport the same carbohydrate, with at least three PTSs being involved in fructose transport and several PTSs and permeases being involved in glucose transport. In the intracellular environment, carbohydrates are phosphorylated and processed to fructose-6-phosphate (Fru-6-P) and fermented by glycolysis with production of organic acids, mainly lactic acid. In addition, glucosamine-6-phosphate (GlcN-6-P) is synthesized from Fru-6-P and serves as an initial precursor for cell wall biosynthesis. Cells can synthesize an intracellular polysaccharide (IPS), a polymer of the glycogen-amylopectin type, when carbohydrates are in excess that can be stored as intracellular granules and are used as an energy source reserve during starvation.

Carbon Catabolite Repression

Most bacteria have evolved regulatory capacities that enable them to respond efficiently to changes in carbon source and thereby shift gene regulation, a phenomenon called carbon catabolite repression (33, 34). The majority of low-GC Gram-positive bacteria depend on a LacI-type transcriptional regulator called CcpA to ensure that catabolic genes for less preferred carbohydrates are suppressed when a preferred carbohydrate (normally glucose) is present. Interestingly, S. mutans deviates from this paradigm in that CcpA plays a less direct role. Instead, the glucose/mannose-PTS (EIIMan) system regulates the expression of catabolic operons required for assimilating secondary carbohydrates such as oligo- and disaccharides (35). Inactivation of manL, which encodes the A and B domains of the EIIMan permease, results in enhanced expression of the fruAB and levDEFG (EIILev) operons. These operons contain genes which encode two different fructanases, FruAB for hydrolyzing fructose polymers (36), and a fructose/mannose-PTS (37), respectively. As a result, a manL mutant demonstrates improved growth on media supplemented with fructose polymers such as inulin or levan (35). CcpA and its cofactor HPr-Ser-P are also involved in this regulation (38, 39). Whereas CcpA interacts directly with cognate cis-elements called cre (catabolite response element) near the fruA promoter, ManL influences fruAB and levDEFG expression independently of CcpA (39). It is now believed that EIIMan-dependent glucose transport influences carbohydrate metabolism via substrate-specific signaling, which occurs primarily at submillimolar concentrations of carbohydrate (38). However, substrate-level regulation is also influenced indirectly by CcpA under excess-carbohydrate conditions, since CcpA appears to regulate the transcription of manL (38, 39). A transcriptomic study of a manL deletion strain validated the key roles of EIIMan in global gene regulation (40), and transcriptional studies of a ccpA deletion strain revealed both a central role for CcpA in controlling carbon flux and the existence of a substantial network of CcpA-independent genes (41, 42).

Catch and Release

To further explore substrate-dependent carbon catabolite repression in S. mutans, Zeng et al. assessed the relative contributions of various sucrolytic enzymes (31). The majority (>95%) of sucrose encountered by S. mutans is believed to be internalized via the EIIScr PTS (43, 44), while the rest is likely metabolized extracellularly by the glucosyltransferases (GTFs) and fructosyltransferase. Enhanced transcription of the fruAB and EIILev operons was observed in the presence of sucrose, with such activation requiring both the sucrose PTS (ScrA) and the LevQRST regulatory pathways. LevQRST is an unconventional four-component system that activates transcription of fruAB and EIILev in response to extracellular fructose or mannose (37, 45). Since free fructose was detected in the culture media of an S. mutans strain deficient in all extracellular sucrolytic enzymes after treatment with sucrose (46), it was hypothesized that following sucrose internalization and subsequent cleavage of sucrose-6-P into glucose-6-P and unphosphorylated fructose by the ScrB hydrolase, some of the fructose is released into the medium and can activate the LevQRST circuit but is insufficient to trigger CcpA-dependent carbon catabolite repression. Such a strategy of carbohydrate metabolism would be energetically efficient and avoid perturbing intracellular ATP levels, which is particularly important to a bacterium such as S. mutans that actively pumps protons out of the cell at the expense of ATP to maintain pH homeostasis. Interestingly, fructose may not be the only carbohydrate to be released and reinternalized by S. mutans. Recent studies have characterized maltose and maltooligosaccharide metabolism and demonstrated the presence of free glucose in the culture medium that is apparently reinternalized by way of the glucose-PTS EIIMan (47, 48). Transient expulsion of glucose was also observed when S. mutans was grown on a mixture of glucose and lactose (49). Considering diffusion limitations within biofilm matrices (50), hexose release may likely serve as temporary energy storage and/or as a carbohydrate source for neighboring cells that may not be actively invested in metabolizing these disaccharides. This would thereby represent a bet-hedging strategy within the population and also contribute to a mutualistic relationship with other microorganisms that are closely associated with S. mutans (51, 52).

BIOFILM FORMATION

As a major etiological agent of human dental caries, S. mutans lives primarily in biofilms on the tooth surfaces, the so-called dental plaque. Strains of S. mutans produce up to three GTFs, GtfB, -C and, -D, that utilize the glucose moiety of sucrose as the substrate to synthesize glucose polymers of glucans (also known as mutans) (Fig. 1) (7). GtfB synthesizes water-insoluble glucans rich in α(1-3)-linkages, GtfC produces a mixture of soluble glucans rich in α(1-6)-linkages and insoluble glucans, and GtfD makes primarily soluble glucans (often called dextran). These polymers, especially the α3,1-linked water-insoluble glucans, are major constituents of plaque biofilm matrices. Gtfs also bind to other oral microbes, even those that do not naturally express Gtfs, thereby converting them into de facto glucan producers (7). In addition, S. mutans encodes several surface-associated glucan-binding proteins, GbpA, -B, -C, and -D. Together, the Gtfs, Gbps, and adhesive glucans serve as an integrated scaffold for sucrose-dependent biofilm formation central to this organism’s cariogenicity by promoting the local accumulation of microbial cells while forming a diffusion-limiting polymeric matrix that protects the embedded bacteria (Fig. 2).

FIGURE 2.

FIGURE 2

Biofilm formation and host-pathogen interactions in S. mutans. Early colonizers (e.g., S. gordonii, Streptococcus mitis, and Actinomyces spp. among others) attach to the tooth enamel via salivary proteins and start to form three-dimensional biofilms under noncariogenic conditions. At pH levels close to neutrality, production of H2O2 by peroxigenic bacteria and other antimicrobial products produced by oral commensals prevents the overgrowth of specific pathogens (e.g., S. mutans) on dental biofilms. Glycosyltransferases (GTFs) secreted by S. mutans adsorb onto the enamel pellicle or bacterial surfaces. In the presence of sucrose, GTFs catabolize sucrose to produce large amounts of insoluble and soluble glucans, which contribute to the buildup of a robust extracellular polysaccharide matrix (EPS), particularly insoluble components. The EPS matrix serves as an architectural scaffold for the biofilm structure, mediating tight adherence to the tooth enamel and bacteria, as glucans provide binding sites for S. mutans glucan-binding proteins (GBP) and other organisms. Extracellular DNA (eDNA) is another functional constituent of the oral biofilm matrix, forming nanofibers that connect cell to cell and cell to substratum and that contribute to biofilm structural integrity and stability. Continuous intake of sucrose by the host leads to a series of ecological and structural shifts that favor the growth of aciduric and highly acidogenic bacteria, such as S. mutans. These changes alter the oral biofilm metabolism so that copious amounts of organic acids are produced, contributing to a decrease in environmental pH. Once S. mutans becomes dominant, the secretion of large amounts of mutacins kills nearby competitors such as peroxigenic streptococci. The constant low-pH milieu surrounding the hydroxyapatite structure of the enamel leads to demineralization and initiates the carious process.

S. mutans also possesses multiple high-affinity surface adhesins that enable colonization even in the absence of sucrose. One of the most widely studied adhesins is the dual antigen I/II, also known as P1, SpaP, or PAc. This structurally complex multifunctional adhesin mediates bacterial attachment to the tooth’s salivary pellicle via interactions with the host scavenger receptor glycoprotein GP340 or DMBT-1 (5355). The AgI/II family adhesins also interact with other bacteria and host proteins such as fibronectin and collagen (53, 56). Relative to the wild type, a P1-deficient mutant demonstrates reduced binding to saliva or GP340-coated surfaces, aberrant biofilm formation, and reduced cariogenicity in a rat caries model (57, 58). In addition, P1 and WapA, another surface-localized adhesin, have been recently shown to form fibrillar amyloid aggregates (59). Amyloids are increasingly recognized as integral bacterial biofilm matrix components that interact with extracellular DNA (eDNA) and confer stability to the exopolysaccharide matrix (60). An srtA mutant lacking the only surface-anchoring sortase enzyme found in S. mutans is severely defective in biofilm development and does not produce amyloid, suggesting that fibril nucleation occurs at the cell surface (61). Treatment of S. mutans with known amyloid inhibitors inhibits biofilm formation via P1 and WapA-dependent mechanisms (59). In addition to P1 and WapA, a third amyloidogenic protein (SMU_63c) was recently identified. This secretory protein serves as an apparent negative regulator of biofilm cell density and genetic competence (59). Its production is associated with K+ availability and influenced by growth phase (62).

Several cell envelope-associated proteins also contribute to S. mutans biofilm formation, including AtlA, RgpG, BrpA, and Psr. AtlA is an autolysin whose deficiency results in decreased autolysis and longer chain length and drastically reduces biofilm formation regardless of the carbohydrate used for growth (63). RgpG is the first enzyme of the biosynthetic pathway for rhamnose-containing glucose polymers, a major surface antigen of oral streptococci responsible for the different serotypes (64, 65). RgpG deficiency does not impair growth but leads to a pronounced reduction of cell surface antigens and major defects in cell morphology and cell division (65). RgpG-deficient mutants display long chains of swollen “squarish” dividing cells and form fewer biofilms irrespective of carbohydrate source. The BrpA and Psr proteins are members of the LytR-CpsA-Psr family of proteins that are widespread in Gram-positive bacteria (6668). Deletion of brpA has little effect on growth but causes major impairment in biofilm formation. The brpA mutant is also less tolerant to acid and oxidative stresses and more susceptible to cell envelope antimicrobial agents, all of which likely contribute to its reduced biofilm phenotype. Psr also strongly influences S. mutans biofilm formation and acid tolerance, but unlike BrpA, Psr deficiency does not diminish oxidative stress tolerance or resistance to cell envelope antimicrobial agents. Both BrpA and Psr exhibit ligase functions for cell wall antigens, such as the rhamnose-containing glucose polymers, and thereby globally impact cell envelope composition. Deficiency of either BrpA or Psr results in a reduction of cell wall antigens and their concurrent accumulation in cell-free culture medium (65). Finally, eDNA is another functional constituent of the S. mutans biofilm matrix; eDNA forms nanofibers that connect cells to one another and to the substratum contributing to bacterial adherence and biofilm structural integrity and stability (69).

STRESS TOLERANCE

The ability of S. mutans to adapt to sudden and substantial environmental changes within the dental plaque is a key attribute that contributes to its status as the major etiologic agent of dental caries. Fermentable carbohydrates consumed by the host provide a substrate for S. mutans and other lactic acid bacteria that ultimately results in the production of acidic end products that accumulate within the biofilm. To thrive at low pH values, S. mutans mounts the so-called acid tolerance response, a robust transcriptional and physiologic adaptation mechanism that encompasses the induction of pathways that contribute to cytoplasm buffering and changes in membrane fatty acid composition, ultimately protecting the cellular machinery from acid damage and contributing to the survival of the bacteria during stress (Fig. 3) (3, 6, 70). Collectively, the different cellular processes that constitute the acid tolerance response contribute to the ability of S. mutans to maintain an intracellular pH that is more alkaline than the surrounding environment (ΔpH) by about 0.5 to 1 pH unit (71). Environmental acidification also triggers S. mutans to modify the composition of the plasma membrane in a way that may alter proton permeability. These modifications are accomplished by increasing the proportion of monounsaturated fatty acids (both by incorporating exogenous fatty acids and by de novo synthesis) and by increasing the length of the carbon chains composing these membrane fatty acids (72). Inactivation of the gene responsible for biosynthesis of monounsaturated fatty acids in S. mutans, fabM, results in extreme sensitivity to low pH, inability to maintain ΔpH, and reduced virulence in a rat caries model (73, 74). In addition to changes in fatty acid composition, the phospholipid cardiolipin has also emerged as an important contributor to acid tolerance, because deletion of the cardiolipin synthase (cls) increased acid sensitivity (75).

FIGURE 3.

FIGURE 3

Acid stress tolerance mechanisms of S. mutans. The ability of S. mutans to catalyze fermentable dietary carbohydrates into organic acids can promptly drop the environmental pH. Exposure to sublethal low pH triggers an acid-adaptive response known as ATR (acid tolerance response), which is a robust transcriptional and physiologic adaptation mechanism for pH homeostasis through alteration of proton permeability, generation of neutralizing molecules, and changes in membrane fatty acid composition. The membrane F1F0-ATPase (F-ATPase) is transcriptionally induced by low pH and serves as the primary mechanism by which protons are extruded to maintain pH homeostasis. The modifications in membrane composition refer to an increase in the proportion of monounsaturated fatty acids (UFA) over saturated fatty acids (SFA) and in the length of the carbon chains composing the membrane fatty acids. Production of neutralizing molecules, such as ammonia and CO2, is also an important way to cope with acid stress. In S. mutans, the agmatine deiminase system (AgDS) converts agmatine, a decarboxylated derivative of arginine found in dental plaque, to ammonia, CO2, putrescine, and ATP. The ammonia generated internally may contribute to cytoplasmic buffering, while the ATP generated can be used to fuel proton extrusion via the F-ATPase. A decrease in environmental pH also triggers activation of malolactic fermentation (MLF), which converts malate to the less acidic lactate and to CO2. The CO2 product can then be used for cytoplasmic neutralization by conversion to bicarbonate (HCO3) via carbonic anhydrase.

Alkalinization of the cytoplasm occurs either by pumping protons out of the cell or through the generation of neutralizing molecules. In S. mutans, the membrane-bound F1F0-ATPase (F-ATPase) is the primary mechanism by which protons are extruded to maintain pH homeostasis. The S. mutans F-ATPase is transcriptionally induced by low pH values and has an optimal pH of 6.0, which is lower than that of most streptococci associated with oral health (76, 77). Some oral streptococci utilize the urease enzyme (e.g., Streptococcus salivarius) or the arginine deiminase system (e.g., Streptococcus gordonii) to produce the neutralizing molecules ammonia and CO2 in order to cope with acid stress. Although these pathways are absent in S. mutans, the agmatine deiminase system (AgDS), analogous to the arginine deiminase system, is present in this species (78, 79). The AgDS converts agmatine, a decarboxylated derivative of arginine found in dental plaque, to ammonia, CO2, putrescine, and ATP. Though the AgDS does not appear to have a considerable impact on environmental alkalinization, the ammonia generated internally may contribute to neutralization of the cytoplasmic pH, while the ATP generated can be used to fuel proton extrusion via the F-ATPase (80). Malolactic fermentation converts malate, an acid commonly found in wine and in fruits such as apples, to the less acidic lactate and to CO2. The CO2 product can then be used for cytoplasmic neutralization by conversion to bicarbonate via carbonic anhydrase. In S. mutans, transcription of the genes encoding the malolactic enzyme and permease is acid-inducible, and malolactic fermentation activity was found to be optimal at an extracellular pH of 4.0 (81). Most importantly, malate was shown to protect S. mutans against acid killing and was associated with maintenance of ATP pools during starvation (82).

While the dental plaque environment was initially thought to be anaerobic, it is now known that the oral microbial community has a high capacity to reduce oxygen, resulting in the generation of toxic reactive oxygen species (83). Most S. mutans strains are susceptible to exposure to H2O2, which can be generated by metabolism of other species within the dental plaque, such as peroxigenic streptococci, or is contained as a component of oral hygiene and tooth bleaching products. Exposure to high levels of H2O2, and its more damaging breakdown products hydroxyl radical and superoxide anion, can rapidly cause irreversible cellular damage by triggering mismetallation of enzymes, by damaging proteins through oxidation of sulfurous amino acids and metal-binding sites, and by disturbing DNA integrity (84). Although oral streptococci lack catalase, S. mutans utilizes a number of scavenging and protective systems to prevent the accumulation of toxic reactive oxygen species. Among these are a manganese-dependent superoxide dismutase, an alkyl hydroperoxidase reductase, a thioredoxin reductase, and a glutaredoxin system (GshA/B/R) (85). Tight control of free iron in the cell is an important aspect of minimizing exposure to reactive oxygen species, because free radical formation is a direct result of the Fenton chemistry, when H2O2 comes into contact with ferrous iron. For this reason, the iron binding protein Dpr is a critical mediator of oxidative stress exposure in S. mutans (86, 87). Finally, the Spx regulators, SpxA1 and SpxA2, are responsible for the transcriptional activation of virtually every major oxidative stress response gene in S. mutans (85, 88). Not surprisingly, spx deletion strains were ill-equipped to tolerate oxidative challenges and caused fewer sulcal caries lesions in rats fed a highly cariogenic diet (85, 89, 90).

SIGNALING PATHWAYS

Two-Component Signal Transduction Systems (TCSTSs)

TCSTSs play important roles in bacterial adaptation, survival, and virulence by sensing changes in the environment and altering the expression of specific sets of genes to mount coordinated responses to environmental stimuli. In TCSTSs, a signal is sent by phosphotransfer between histidine senor kinases and their cognate response regulators, triggering the response regulators to dimerize and bind to conserved DNA motifs, ultimately tuning cellular functions such as biofilm formation, stress tolerance, and nutrient uptake (91). The genome of the type strain UA159 encodes 14 TCSTSs and one orphan response regulator with no genetic link to a histidine kinase (92). Among those, ComDE, LevRS, VicRK, and the orphan CovR regulator have been studied in some detail and shown to coordinate the expression of a number of virulence attributes. The LevRS system, which is important for management of carbohydrate metabolism, was introduced in the “Carbohydrate Metabolism” session, whereas the ComDE system, which is involved in the regulation of bacteriocin production and competence, is discussed in the next paragraph. VicRK influences acid and oxidative stress responses and competence and is the only TCSTS essential in S. mutans (93, 94). Several studies have proposed phosphotransfer cross talk between VicRK and the LiaFSR TCSTS, which contributes to surface adhesion, mutacin production, and the ability to tolerate environmental stresses, including cell envelope damage and heat shock (9598). In addition, VicRK and CovR directly regulate genes implicated in the synthesis of and interaction with extracellular polysaccharides (7, 99). For example, transcription of gbpB is positively regulated by VicR (100, 101), while gtfB, gtfC, and gbpC are repressed by CovR (99).

Quorum Sensing (QS)

QS systems are communication networks that enable microbes to sense and respond to environmental conditions such as nutrient availability and population density, because signaling molecules naturally accumulate along with bacterial density. In Gram-positive bacteria, QS is coordinated by peptide pheromones, which serve as extracellular signaling molecules that trigger changes in gene expression and, ultimately, activation of a coordinated response by the population (102104). In S. mutans, QS systems have evolved to regulate production of bacteriocins (known in S. mutans as mutacins), which are peptide antibiotics used in defense against other oral microbes (105107) and in competence (natural transformation), a transient state in which the organism is primed to take up foreign DNA (Fig. 4). The competence-stimulating peptide signaling molecule (CSP) (also called the mutacin-inducing peptide) is encoded by comC. Once CSP has been secreted and processed, it is recognized by the TCSTS ComDE (104, 108, 109). Activated (phosphorylated) ComE regulates mutacin production by recognizing a conserved sequence in the promoter region of its target genes (95, 110, 111). Also sharing regulatory links with ComDE in S. mutans is another TCSTS, CiaRH, which contributes to biofilm formation, acid tolerance, and entry into competence, possibly by interacting with CSP (112). Among the consequences of ComE activation is the stimulation of comRS, the QS pathway directly responsible for competence activation via the alternative sigma factor ComX (also called SigX) (113, 114). Once exported to the extracellular space, the prepeptide ComS is presumably processed into the peptide pheromone XIP (comX- or sigX-inducing peptide) (114, 115). When imported back into the cell via the oligopeptide permease system, XIP is sensed by ComR, which binds to conserved inverted repeat sequences upstream of both comX and comS, thereby causing auto-induction of the ComRS pathway and activation of ComX-regulated genes. It is worth noting that while all S. mutans isolates sequenced to date possess a functional ComRS-ComX system, not all strains harbor a complete ComCDE pathway, nor are all isolates equally competent (15).

FIGURE 4.

FIGURE 4

Quorum-sensing systems involved in the regulation of bacteriocin production and competence in S. mutans. Cell density, nutrient availability, and other environmental conditions induce the expression of comC, a gene encoding the competence-stimulating peptide (CSP) precursor. The CSP propeptide is cleaved off inside the cell and exported through a specific ABC transporter encoded by comAB. In the extracellular environment, CSP then undergoes a final postexport processing mediated by the SepM protease. Upon reaching a certain threshold, mature CSP is recognized by the two-component system ComDE, triggering a phosphorylation cascade. Activated (phosphorylated) ComE activates transcription of (i) comC and comDE, creating a positive feedback loop, (ii) genes involved in mutacin production, and (iii) by a yet-to-be-determined mechanism, comRS, the quorum-sensing pathway directly responsible for competence activation via the alternative sigma factor ComX. Once exported to the extracellular milieu, the prepeptide ComS is processed into the peptide pheromone XIP (comX- or sigX-inducing peptide). XIP is transported back into the cell via the oligopeptide permease system (Opp) and sensed by the Rgg-type regulator ComR. Activated ComR binds to both comX and comS promoters, thereby causing auto-induction of ComRS and activation of late (ComX-regulated) competence genes.

The mutacins produced by S. mutans are categorized as either lantibiotics (broadly active against Gram-positive bacteria) or nonlantibiotics (most active against closely related species), and production of these molecules is strain specific (116). Mutacins provide a competitive advantage to S. mutans by inhibiting the growth of neighboring bacterial species (117, 118). A close relationship exists between competence induction and mutacin production, because a threshold concentration of CSP activates ComDE to result in increased mutacin production (95, 111). Adding to the layers of regulation of mutacin production are two LytTR regulatory systems, HdrRM and BrsRM, which include a membrane-bound inhibitor protein that prompts the activity of the transcriptional regulator (119, 120). In this case, an overlap in the regulatory systems that govern mutacin production and competence is again observed because LytTR systems also induce competence through ComX (120, 121). A complete understanding of the environmental conditions that trigger these regulators and hence influence mutacin production is yet to be achieved.

Another S. mutans QS mechanism employs the autoinducer-2 (AI-2), the collective name for a group of furanones formed as a by-product of LuxS-mediated methyl metabolism (122). The lack of species specificity of AI-2 signaling molecules, which are produced by both Gram-positive and Gram-negative organisms, facilitates interspecies communication as population growth contributes to accumulation of AI-2. Deficiency of LuxS reduces the ability of S. mutans to tolerate acid and oxidative stress and to form biofilms, especially during growth in sucrose (123, 124). In agreement with those phenotypes, LuxS deficiency causes alterations in expression of a large number of genes, including those with known roles in stress tolerance response and biofilm formation (123125). Addition of synthetic AI-2 to the growth medium can restore the phenotypes of LuxS mutants with regard to the stress tolerance response, biofilm formation, and the expression of selected genes (124, 125). To date, however, a specific receptor for AI-2 has yet to be identified (125).

Regulatory Nucleotides

The regulatory nucleotides (p)ppGpp and cyclic-di-AMP have also been shown to modulate biofilm formation and stress responses in S. mutans (126128). Guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp), collectively called (p)ppGpp, are the effector molecules of a conserved stress response referred to as the stringent response (129). Three (p)ppGpp-metabolizing enzymes have been identified in S. mutans: RelA is a bifunctional synthetase/hydrolase contributing to metabolism of (p)ppGpp, while two small alarmone synthetase enzymes, RelP and RelQ, harbor only the synthetase domain (130). In S. mutans, changes in (p)ppGpp pools affect biofilm formation, carbohydrate metabolism, and stress tolerance, suggesting an overlap between circuits that govern general stress tolerance and biofilm formation. While the mechanism is not completely understood, (p)ppGpp pools also modulate competence signaling through interactions with an ABC-type transporter, RcrRPQ, and at least one peptide encoded within rcrQ (126, 131). Cyclic di-AMP is an emerging second messenger in bacteria that has been shown to play important roles in bacterial fitness and virulence (132). In S. mutans, increased cyclic-di-AMP levels promoted biofilm formation through interactions with the VicRK-gtfB network that ultimately resulted in in the transcriptional activation of gtfB (128).

INTERSPECIES AND CROSS-KINGDOM INTERACTIONS

Interactions between S. mutans and certain members of the dental plaque community have been documented and have recently been shown to exert a major influence on the development and pathogenicity of plaque. These interactions can be synergistic, i.e., promote S. mutans growth, or antagonistic, i.e., inhibitory to S. mutans. A classic example of an antagonistic interaction occurs between S. mutans and members of the mitis streptococci group such as Streptococcus sanguinis and S. gordonii. Specifically, several members of the mitis group secrete millimolar concentrations of H2O2, which can be highly inhibitory to S. mutans (118). On the other hand, strains of S. mutans not only produce mutacins that are specific against mitis streptococci, but most are also generally more aciduric than species from the mitis group. This antagonistic relationship becomes more evident in dental plaque, whereby there is an inverse association between the abundance of oral commensal streptococci such as S. sanguinis and S. gordonii (abundant in healthy plaque) and that of S. mutans (abundant in caries lesions) (133) (Fig. 2).

While production of lactic acid by S. mutans is inhibitory to the growth of many acid-sensitive oral commensals, lactic acid serves as a carbon source for Veillonella spp., a prevalent genus in the oral cavity (134). Thus, it is thought that Veillonella may act as an “acid sink,” preventing the dental biofilm from reaching extremely low pH values that even aciduric organisms such as S. mutans may not be able to survive. This nutritional mutualism may explain the close association of Veillonella with streptococci in the oral cavity, which excrete lactate as a waste product of carbohydrate fermentation. In dual-species biofilms, S. mutans and Veillonella parvula form distinctive structures and display increased resistance to chlorhexidine and other antimicrobials when compared to single-species biofilms (135, 136). Using a three-species mixed culture, Liu et al. showed that the presence of V. parvula negated the growth inhibition of S. mutans caused by peroxigenic S. gordonii (137).

In addition to bacteria, the oral cavity is also colonized by yeasts. Candida albicans in particular is frequently found in the oral mucosa. Interestingly, C. albicans is often associated with S. mutans and detected in high numbers in cases of early childhood caries (138). Recent studies have shown that the S. mutans GtfB enzyme binds to mannan receptors on the C. albicans surface, leading to enhanced adherence and biofilm accumulation by C. albicans and thereby enhancing biofilm formation and cariogenicity (139, 140). At the same time, C. albicans synthesizes farnesol, which enhances extracellular polysaccharide production by S. mutans (52). In a rat caries model, coinfection with S. mutans and C. albicans led to higher levels of microbial carriage in plaque biofilms and significantly increased the cariogenic potential of dental plaque, resulting in aggressive disease onset and rampant caries lesions (140).

S. MUTANS AS A MODEL ORGANISM: SHIFTING LONG-STANDING PARADIGMS

Key advances in the field of bacteriology have come from studies with Escherichia coli and Bacillus subtilis, which represent the Gram-negative and Gram-positive bacterial paradigms, respectively. Despite the important contributions of these two species to bacteriology research, no model organism is a perfect representative of other species. In the case of Gram-positive organisms, B. subtilis is a free-living sporulating organism found in soil and plants but not in humans. Conversely, S. mutans is an obligate human pathogen with a biofilm-dependent lifestyle. It does not come as a surprise that a greater overlap in the mechanisms of gene regulation and metabolic pathways are observed between S. mutans and related Gram-positive pathogens that share a host-associated lifestyle. Such organisms, like S. mutans, generally have compact genomes with low GC contents. Like E. coli and B. subtilis, S. mutans is highly amenable to genetic manipulation and is therefore also easy to study and control in the laboratory setting. Among closely related streptococci, it has the most complete and sophisticated set of genetic tools that can be used in combination with simple and efficient in vitro and in vivo models to enhance our current understanding of S. mutans biology and beyond (141). As a result, a number of S. mutans investigations have challenged long-standing bacterial dogmas that were established based on work conducted with E. coli and B. subtilis. One such example is the signal recognition particle (SRP) pathway involved in cotranslational protein translocation (142). The first clue that protein transport in S. mutans differs from the established E. coli model came from the identification of an acid-sensitive transposon mutant in which ffh encoding the 54-kilodalton homolog of the eukaryotic SRP was insertionally inactivated. Subsequently, all three conserved bacterial elements of the cotranslational translocation SRP pathway, including the particle components Ffh and small 4.5S cytoplasmic RNA, along with the membrane-associated SRP receptor FtsY, were proven dispensable in S. mutans. This was noteworthy because the SRP pathway was long believed to be essential for viability in all living cells. An explanation for this surprise lay in the presence in S. mutans of two paralogs of the YidC/Oxa/Alb family of membrane-localized chaperone insertases found in bacteria, mitochondria, and chloroplasts. Unlike Gram-negative bacteria, most Gram-positive organisms possess two, if not more, YidC homologs. Another almost universal distinguishing feature between Gram-positive and Gram-negative bacteria, also discovered in S. mutans, is the SRP accessory factor YlxM, which interacts with both Ffh and scRNA and influences the GTPase activity of the Ffh/FtsY heterodimer, which is necessary for pathway component recycling once ribosome/nascent protein chain complexes are delivered to the membrane-localized SecYEG translocon (143). Another example occurred during the initial characterization of the enzyme responsible for the synthesis of (p)ppGpp in S. mutans, the effector molecule of the bacterial stringent response (see “Signaling Pathways” section). Before the work with S. mutans, the bifunctional RelA enzyme (also known as Rsh or Rel) was considered the sole enzymatic source of (p)ppGpp synthesis and degradation in all Firmicutes. The serendipitous finding that deletion of relA did not abolish (p)ppGpp production in S. mutans led to the discovery of two additional enzymes, RelP and RelQ, capable of synthesizing (p)ppGpp (130). Subsequent bioinformatics and genetic analysis revealed that these enzymes are ubiquitous in Firmicutes, and they were eventually found in other bacterial species.

S. MUTANS AS A THERAPEUTIC TARGET IN CARIES PREVENTION

While caries is a polymicrobial disease, selective targeting of S. mutans in dental biofilms is viewed as a suitable approach for its prevention. This is mainly because the synthesis of insoluble glucans from sucrose by S. mutans is central for the formation of a stable biofilm matrix that facilitates bacterial colonization of the tooth surface and, at the same time, serves as a diffusion barrier helping to maintain the acidic milieu within which cariogenic bacteria thrive (144). One of the current lines of thought in dental caries prevention is that it may be possible to halt the development of cariogenic biofilms by selectively targeting S. mutans such that the oral microbiome associated with health is not disturbed. Most of the early research conducted in the late 1960s into the 1980s focused on the development of anti-S. mutans vaccines. Despite some recent successes in animal models with vaccines containing or encoding single or a combination of antigens (145148), emphasis on an immunoprophylactic approach has slowed somewhat due to the many challenges in obtaining long-term salivary IgA responses, safety concerns with antistreptococci antibody cross-reactivity, and providing species-specific protection without disrupting related beneficial commensal organisms. Over the past 2 decades or more, a number of natural products, such as propolis (149), curcumin (150), cranberry (151), and green tea extracts (152) among many others, have been shown to be effective against S. mutans biofilms and to prevent dental caries, although to date, none of these products has proven to be selective toward S. mutans. More recently, antimicrobial peptides (AMPs), small molecules, and probiotics have emerged as promising new approaches for the development of novel anticaries strategies that specifically target S. mutans. While AMPs kill bacteria indiscriminately, the selective killing of S. mutans by AMPs has been achieved by creating a synthetic peptide that combines a large-spectrum AMP with the S. mutans-specific CSP (153, 154). Phase 2 clinical trials recently showed that a single varnish application of one such peptide achieved significant reductions of S. mutans in the oral cavity (155). More recently, a small molecule derived from 2-aminotriazole (designated 3F1) was also shown to selectively disperse S. mutans biofilms (156). Most importantly, 3F1 was shown to reduce caries without disturbing the oral microbiome in a rat caries model. An alternative approach to combat S. mutans and therefore prevent dental caries may be the use of alkalinogenic bacteria as a probiotic or the use of substrates for such alkalinogenic activities, e.g., arginine, as a prebiotic. This is because some oral bacteria can neutralize plaque pH by producing large quantities of ammonia by metabolizing arginine or urea, thereby creating an environment favorable to health-associated bacteria (157). A promising candidate is a highly arginolytic streptococcal strain, designated A12, isolated from supragingival plaque of a caries-free individual (158). Not only did the A12 strain neutralize acid by metabolizing arginine, but it was also shown to kill S. mutans by producing H2O2 and to interfere with signaling pathways that control bacteriocin production.

FUTURE PERSPECTIVES

Evidence accumulated over many decades has clearly shown that S. mutans is a major agent in dental caries vis-à-vis its capacity to orchestrate changes in the plaque microbiome via EPS and acid production. Thus, continued efforts to elucidate how S. mutans senses and responds to environmental cues through interconnected circuits that govern stress tolerance and biofilm formation can facilitate the identification of new targets for caries treatment and prevention. As the biology of S. mutans continues to be unraveled, a better understanding of the consequences of genomic and phenotypic heterogeneity among strains is an important area for development. Specifically, how S. mutans isolates with different properties contribute to the different stages of disease through synergistic or antagonistic interactions with the microbiome is a largely unexplored area. Future investigations should also consider the role of certain strains of S. mutans in systemic infections.

ACKNOWLEDGMENTS

We thank Robert A. Burne for suggestions and critical reading of the text.

The authors’ work in this area was supported by NIH-NIDCR grants DE019783, DE022559, DE008007, DE021789, DE024348, DE12236, DE19452, and DE25348.

REFERENCES

  • 1.Clarke JK. 1924. On the bacterial factor in the etiology of dental caries. Br J Exp Pathol 5:141–147. [PubMed] [Google Scholar]
  • 2.Loesche WJ. 1986. Role of Streptococcus mutans in human dental decay. Microbiol Rev 50:353–380. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lemos JA, Burne RA. 2008. A model of efficiency: stress tolerance by Streptococcus mutans. Microbiology 154:3247–3255 10.1099/mic.0.2008/023770-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nakano K, Ooshima T. 2009. Serotype classification of Streptococcus mutans and its detection outside the oral cavity. Future Microbiol 4:891–902 10.2217/fmb.09.64. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 5.Ajdić D, McShan WM, McLaughlin RE, Savić G, Chang J, Carson MB, Primeaux C, Tian R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti JJ. 2002. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A 99:14434–14439 10.1073/pnas.172501299. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Baker JL, Faustoferri RC, Quivey RG Jr. 2017. Acid-adaptive mechanisms of Streptococcus mutans: the more we know, the more we don’t. Mol Oral Microbiol 32:107–117 10.1111/omi.12162. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bowen WH, Koo H. 2011. Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms. Caries Res 45:69–86 10.1159/000324598. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lemos JA, Abranches J, Burne RA. 2005. Responses of cariogenic streptococci to environmental stresses. Curr Issues Mol Biol 7:95–107. [PubMed] [PubMed] [Google Scholar]
  • 9.Hamada S, Slade HD. 1980. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 44:331–384. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Argimón S, Konganti K, Chen H, Alekseyenko AV, Brown S, Caufield PW. 2014. Comparative genomics of oral isolates of Streptococcus mutans by in silico genome subtraction does not reveal accessory DNA associated with severe early childhood caries. Infect Genet Evol 21:269–278 10.1016/j.meegid.2013.11.003. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Liu L, Hao T, Xie Z, Horsman GP, Chen Y. 2016. Genome mining unveils widespread natural product biosynthetic capacity in human oral microbe Streptococcus mutans. Sci Rep 6:37479 10.1038/srep37479. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Maruyama F, Kobata M, Kurokawa K, Nishida K, Sakurai A, Nakano K, Nomura R, Kawabata S, Ooshima T, Nakai K, Hattori M, Hamada S, Nakagawa I. 2009. Comparative genomic analyses of Streptococcus mutans provide insights into chromosomal shuffling and species-specific content. BMC Genomics 10:358 10.1186/1471-2164-10-358. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Meng P, Lu C, Zhang Q, Lin J, Chen F. 2017. Exploring the genomic diversity and cariogenic differences of Streptococcus mutans strains through pan-genome and comparative genome analysis. Curr Microbiol 74:1200–1209 10.1007/s00284-017-1305-z. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 14.Cornejo OE, Lefébure T, Bitar PD, Lang P, Richards VP, Eilertson K, Do T, Beighton D, Zeng L, Ahn SJ, Burne RA, Siepel A, Bustamante CD, Stanhope MJ. 2013. Evolutionary and population genomics of the cavity causing bacteria Streptococcus mutans. Mol Biol Evol 30:881–893 10.1093/molbev/mss278. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Palmer SR, Miller JH, Abranches J, Zeng L, Lefebure T, Richards VP, Lemos JA, Stanhope MJ, Burne RA. 2013. Phenotypic heterogeneity of genomically-diverse isolates of Streptococcus mutans. PLoS One 8:e61358 10.1371/journal.pone.0061358. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lembo FL, Longo PL, Ota-Tsuzuki C, Rodrigues CR, Mayer MP. 2007. Genotypic and phenotypic analysis of Streptococcus mutans from different oral cavity sites of caries-free and caries-active children. Oral Microbiol Immunol 22:313–319 10.1111/j.1399-302X.2007.00361.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 17.Napimoga MH, Höfling JF, Klein MI, Kamiya RU, Gonçalves RB. 2005. Tansmission, diversity and virulence factors of Sreptococcus mutans genotypes. J Oral Sci 47:59–64 10.2334/josnusd.47.59. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 18.Phattarataratip E, Olson B, Broffitt B, Qian F, Brogden KA, Drake DR, Levy SM, Banas JA. 2011. Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides. Mol Oral Microbiol 26:187–199 10.1111/j.2041-1014.2011.00607.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kim JN, Stanhope MJ, Burne RA. 2013. Core-gene-encoded peptide regulating virulence-associated traits in Streptococcus mutans. J Bacteriol 195:2912–2920 10.1128/JB.00189-13. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zeng L, Xue P, Stanhope MJ, Burne RA. 2013. A galactose-specific sugar: phosphotransferase permease is prevalent in the non-core genome of Streptococcus mutans. Mol Oral Microbiol 28:292–301 10.1111/omi.12025. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Abranches J, Miller JH, Martinez AR, Simpson-Haidaris PJ, Burne RA, Lemos JA. 2011. The collagen-binding protein Cnm is required for Streptococcus mutans adherence to and intracellular invasion of human coronary artery endothelial cells. Infect Immun 79:2277–2284 10.1128/IAI.00767-10. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nomura R, Nakano K, Naka S, Nemoto H, Masuda K, Lapirattanakul J, Alaluusua S, Matsumoto M, Kawabata S, Ooshima T. 2012. Identification and characterization of a collagen-binding protein, Cbm, in Streptococcus mutans. Mol Oral Microbiol 27:308–323 10.1111/j.2041-1014.2012.00649.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 23.Otsugu M, Nomura R, Matayoshi S, Teramoto N, Nakano K. 2017. Contribution of Streptococcus mutans strains with collagen-binding proteins in the presence of serum to the pathogenesis of infective endocarditis. Infect Immun 85:e00401-17- 10.1128/IAI.00401-17. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Freires IA, Avilés-Reyes A, Kitten T, Simpson-Haidaris PJ, Swartz M, Knight PA, Rosalen PL, Lemos JA, Abranches J. 2017. Heterologous expression of Streptococcus mutans Cnm in Lactococcus lactis promotes intracellular invasion, adhesion to human cardiac tissues and virulence. Virulence 8:18–29 10.1080/21505594.2016.1195538. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lapirattanakul J, Nakano K, Nomura R, Leelataweewud P, Chalermsarp N, Klaophimai A, Srisatjaluk R, Hamada S, Ooshima T. 2011. Multilocus sequence typing analysis of Streptococcus mutans strains with the cnm gene encoding collagen-binding adhesin. J Med Microbiol 60:1677–1684 10.1099/jmm.0.033415-0. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 26.Nomura R, Naka S, Nemoto H, Inagaki S, Taniguchi K, Ooshima T, Nakano K. 2013. Potential involvement of collagen-binding proteins of Streptococcus mutans in infective endocarditis. Oral Dis 19:387–393 10.1111/odi.12016. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 27.Misaki T, Naka S, Hatakeyama R, Fukunaga A, Nomura R, Isozaki T, Nakano K. 2016. Presence of Streptococcus mutans strains harbouring the cnm gene correlates with dental caries status and IgA nephropathy conditions. Sci Rep 6:36455 10.1038/srep36455. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Miyatani F, Kuriyama N, Watanabe I, Nomura R, Nakano K, Matsui D, Ozaki E, Koyama T, Nishigaki M, Yamamoto T, Mizuno T, Tamura A, Akazawa K, Takada A, Takeda K, Yamada K, Nakagawa M, Ihara M, Kanamura N, Friedland RP, Watanabe Y. 2015. Relationship between Cnm-positive Streptococcus mutans and cerebral microbleeds in humans. Oral Dis 21:886–893 10.1111/odi.12360. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 29.Miller JH, Avilés-Reyes A, Scott-Anne K, Gregoire S, Watson GE, Sampson E, Progulske-Fox A, Koo H, Bowen WH, Lemos JA, Abranches J. 2015. The collagen binding protein Cnm contributes to oral colonization and cariogenicity of Streptococcus mutans OMZ175. Infect Immun 83:2001–2010 10.1128/IAI.03022-14. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Esberg A, Sheng N, Mårell L, Claesson R, Persson K, Borén T, Strömberg N. 2017. Streptococcus mutans adhesin biotypes that match and predict individual caries development. EBioMedicine 24:205–215 10.1016/j.ebiom.2017.09.027. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zeng L, Burne RA. 2013. Comprehensive mutational analysis of sucrose-metabolizing pathways in Streptococcus mutans reveals novel roles for the sucrose phosphotransferase system permease. J Bacteriol 195:833–843 10.1128/JB.02042-12. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR III, Heydorn A, Koo H. 2012. The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm. PLoS Pathog 8:e1002623 10.1371/journal.ppat.1002623. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Deutscher J. 2008. The mechanisms of carbon catabolite repression in bacteria. Curr Opin Microbiol 11:87–93 10.1016/j.mib.2008.02.007. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 34.Deutscher J, Francke C, Postma PW. 2006. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev 70:939–1031 10.1128/MMBR.00024-06. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Abranches J, Chen YY, Burne RA. 2003. Characterization of Streptococcus mutans strains deficient in EIIABMan of the sugar phosphotransferase system. Appl Environ Microbiol 69:4760–4769 10.1128/AEM.69.8.4760-4769.2003. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Burne RA, Penders JE. 1992. Characterization of the Streptococcus mutans GS-5 fruA gene encoding exo-β-D-fructosidase. Infect Immun 60:4621–4632. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zeng L, Wen ZT, Burne RA. 2006. A novel signal transduction system and feedback loop regulate fructan hydrolase gene expression in Streptococcus mutans. Mol Microbiol 62:187–200 10.1111/j.1365-2958.2006.05359.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 38.Zeng L, Burne RA. 2008. Multiple sugar: phosphotransferase system permeases participate in catabolite modification of gene expression in Streptococcus mutans. Mol Microbiol 70:197–208 10.1111/j.1365-2958.2008.06403.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zeng L, Burne RA. 2010. Seryl-phosphorylated HPr regulates CcpA-independent carbon catabolite repression in conjunction with PTS permeases in Streptococcus mutans. Mol Microbiol 75:1145–1158 10.1111/j.1365-2958.2009.07029.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Abranches J, Candella MM, Wen ZT, Baker HV, Burne RA. 2006. Different roles of EIIABMan and EIIGlc in regulation of energy metabolism, biofilm development, and competence in Streptococcus mutans. J Bacteriol 188:3748–3756 10.1128/JB.00169-06. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Abranches J, Nascimento MM, Zeng L, Browngardt CM, Wen ZT, Rivera MF, Burne RA. 2008. CcpA regulates central metabolism and virulence gene expression in Streptococcus mutans. J Bacteriol 190:2340–2349 10.1128/JB.01237-07. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zeng L, Choi SC, Danko CG, Siepel A, Stanhope MJ, Burne RA. 2013. Gene regulation by CcpA and catabolite repression explored by RNA-Seq in Streptococcus mutans. PLoS One 8:e60465 10.1371/journal.pone.0060465. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chassy BM, Porter EV. 1979. Initial characterization of sucrose-6-phosphate hydrolase from Streptococcus mutans and its apparent identity with intracellular invertase. Biochem Biophys Res Commun 89:307–314 10.1016/0006-291X(79)90979-3. [DOI] [PubMed] [Google Scholar]
  • 44.Tanzer JM, Chassy BM, Krichevsky MI. 1971. Sucrose metabolism by Streptococcus mutans, SL-I. Biochim Biophys Acta 261:379–387 10.1016/0304-4165(72)90062-1. [DOI] [PubMed] [Google Scholar]
  • 45.Zeng L, Das S, Burne RA. 2011. Genetic analysis of the functions and interactions of components of the LevQRST signal transduction complex of Streptococcus mutans. PLoS One 6:e17335 10.1371/journal.pone.0017335. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zeng L, Burne RA. 2015. Sucrose- and fructose-specific effects on the transcriptome of Streptococcus mutans, as determined by RNA sequencing. Appl Environ Microbiol 82:146–156 10.1128/AEM.02681-15. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sato Y, Okamoto-Shibayama K, Azuma T. 2013. The malQ gene is essential for starch metabolism in Streptococcus mutans. J Oral Microbiol 5:21285 10.3402/jom.v5i0.21285. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sato Y, Okamoto-Shibayama K, Azuma T. 2015. Glucose-PTS involvement in maltose metabolism by Streptococcus mutans. Bull Tokyo Dent Coll 56:93–103 10.2209/tdcpublication.56.93. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 49.Liberman ES, Bleiweis AS. 1984. Role of the phosphoenolpyruvate-dependent glucose phosphotransferase system of Streptococcus mutans GS5 in the regulation of lactose uptake. Infect Immun 43:536–542. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Klein MI, Hwang G, Santos PH, Campanella OH, Koo H. 2015. Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms. Front Cell Infect Microbiol 5:10 10.3389/fcimb.2015.00010. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.He J, Kim D, Zhou X, Ahn SJ, Burne RA, Richards VP, Koo H. 2017. RNA-Seq reveals enhanced sugar metabolism in Streptococcus mutans co-cultured with Candida albicans within mixed-species biofilms. Front Microbiol 8:1036 10.3389/fmicb.2017.01036. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kim D, Sengupta A, Niepa TH, Lee BH, Weljie A, Freitas-Blanco VS, Murata RM, Stebe KJ, Lee D, Koo H. 2017. Candida albicans stimulates Streptococcus mutans microcolony development via cross-kingdom biofilm-derived metabolites. Sci Rep 7:41332 10.1038/srep41332. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, Deivanayagam CC, Jenkinson HF. 2010. The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol Microbiol 77:276–286 10.1111/j.1365-2958.2010.07212.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Larson MR, Rajashankar KR, Crowley PJ, Kelly C, Mitchell TJ, Brady LJ, Deivanayagam C. 2011. Crystal structure of the C-terminal region of Streptococcus mutans antigen I/II and characterization of salivary agglutinin adherence domains. J Biol Chem 286:21657–21666 10.1074/jbc.M111.231100. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Jakubovics NS, Strömberg N, van Dolleweerd CJ, Kelly CG, Jenkinson HF. 2005. Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands. Mol Microbiol 55:1591–1605 10.1111/j.1365-2958.2005.04495.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 56.Sullan RM, Li JK, Crowley PJ, Brady LJ, Dufrêne YF. 2015. Binding forces of Streptococcus mutans P1 adhesin. ACS Nano 9:1448–1460 10.1021/nn5058886. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ahn SJ, Ahn SJ, Wen ZT, Brady LJ, Burne RA. 2008. Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun 76:4259–4268 10.1128/IAI.00422-08. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Crowley PJ, Brady LJ, Michalek SM, Bleiweis AS. 1999. Virulence of a spaP mutant of Streptococcus mutans in a gnotobiotic rat model. Infect Immun 67:1201–1206. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Besingi RN, Wenderska IB, Senadheera DB, Cvitkovitch DG, Long JR, Wen ZT, Brady LJ. 2017. Functional amyloids in Streptococcus mutans, their use as targets of biofilm inhibition and initial characterization of SMU_63c. Microbiology 163:488–501 10.1099/mic.0.000443. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Taglialegna A, Lasa I, Valle J. 2016. Amyloid structures as biofilm matrix scaffolds. J Bacteriol 198:2579–2588 10.1128/JB.00122-16. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Oli MW, Otoo HN, Crowley PJ, Heim KP, Nascimento MM, Ramsook CB, Lipke PN, Brady LJ. 2012. Functional amyloid formation by Streptococcus mutans. Microbiology 158:2903–2916 10.1099/mic.0.060855-0. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Binepal G, Wenderska IB, Crowley P, Besingi RN, Senadheera DB, Jeannine Brady L, Cvitkovitch DG. 2017. K+ modulates genetic competence and the stress regulon of Streptococcus mutans. Microbiology 163:719–730 10.1099/mic.0.000458. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Brown TA Jr, Ahn SJ, Frank RN, Chen YY, Lemos JA, Burne RA. 2005. A hypothetical protein of Streptococcus mutans is critical for biofilm formation. Infect Immun 73:3147–3151 10.1128/IAI.73.5.3147-3151.2005. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Yamashita Y, Shibata Y, Nakano Y, Tsuda H, Kido N, Ohta M, Koga T. 1999. A novel gene required for rhamnose-glucose polysaccharide synthesis in Streptococcus mutans. J Bacteriol 181:6556–6559. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.De A, Liao S, Bitoun JP, Roth R, Beatty WL, Wu H, Wen ZT. 2017. Deficiency of RgpG causes major defects in cell division and biofilm formation, and deficiency of LytR-CpsA-Psr family proteins leads to accumulation of cell wall antigens in culture medium by Streptococcus mutans. Appl Environ Microbiol 83:e00928-17 10.1128/AEM.00928-17. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wen ZT, Burne RA. 2002. Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Appl Environ Microbiol 68:1196–1203 10.1128/AEM.68.3.1196-1203.2002. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Bitoun JP, Liao S, Yao X, Ahn S-J, Isoda R, Nguyen AH, Brady LJ, Burne RA, Abranches J, Wen ZT. 2012. BrpA is involved in regulation of cell envelope stress responses in Streptococcus mutans. Appl Environ Microbiol 78:2914–2922 10.1128/AEM.07823-11. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Bitoun JP, Liao S, McKey BA, Yao X, Fan Y, Abranches J, Beatty WL, Wen ZT. 2013. Psr is involved in regulation of glucan production, and double deficiency of BrpA and Psr is lethal in Streptococcus mutans. Microbiology 159:493–506 10.1099/mic.0.063032-0. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Liao S, Klein MI, Heim KP, Fan Y, Bitoun JP, Ahn SJ, Burne RA, Koo H, Brady LJ, Wen ZT. 2014. Streptococcus mutans extracellular DNA is upregulated during growth in biofilms, actively released via membrane vesicles, and influenced by components of the protein secretion machinery. J Bacteriol 196:2355–2366 10.1128/JB.01493-14. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Matsui R, Cvitkovitch D. 2010. Acid tolerance mechanisms utilized by Streptococcus mutans. Future Microbiol 5:403–417 10.2217/fmb.09.129. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Bender GR, Sutton SV, Marquis RE. 1986. Acid tolerance, proton permeabilities, and membrane ATPases of oral streptococci. Infect Immun 53:331–338. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Fozo EM, Quivey RG Jr. 2004. Shifts in the membrane fatty acid profile of Streptococcus mutans enhance survival in acidic environments. Appl Environ Microbiol 70:929–936 10.1128/AEM.70.2.929-936.2004. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Fozo EM, Quivey RG Jr. 2004. The fabM gene product of Streptococcus mutans is responsible for the synthesis of monounsaturated fatty acids and is necessary for survival at low pH. J Bacteriol 186:4152–4158 10.1128/JB.186.13.4152-4158.2004. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Fozo EM, Scott-Anne K, Koo H, Quivey RG Jr. 2007. Role of unsaturated fatty acid biosynthesis in virulence of Streptococcus mutans. Infect Immun 75:1537–1539 10.1128/IAI.01938-06. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.MacGilvray ME, Lapek JD Jr, Friedman AE, Quivey RG Jr. 2012. Cardiolipin biosynthesis in Streptococcus mutans is regulated in response to external pH. Microbiology 158:2133–2143 10.1099/mic.0.057273-0. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Kuhnert WL, Zheng G, Faustoferri RC, Quivey RG Jr. 2004. The F-ATPase operon promoter of Streptococcus mutans is transcriptionally regulated in response to external pH. J Bacteriol 186:8524–8528 10.1128/JB.186.24.8524-8528.2004. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Sheng J, Marquis RE. 2006. Enhanced acid resistance of oral streptococci at lethal pH values associated with acid-tolerant catabolism and with ATP synthase activity. FEMS Microbiol Lett 262:93–98 10.1111/j.1574-6968.2006.00374.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 78.Griswold AR, Chen YY, Burne RA. 2004. Analysis of an agmatine deiminase gene cluster in Streptococcus mutans UA159. J Bacteriol 186:1902–1904 10.1128/JB.186.6.1902-1904.2004. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Griswold AR, Jameson-Lee M, Burne RA. 2006. Regulation and physiologic significance of the agmatine deiminase system of Streptococcus mutans UA159. J Bacteriol 188:834–841 10.1128/JB.188.3.834-841.2006. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Liu Y, Burne RA. 2009. Multiple two-component systems of Streptococcus mutans regulate agmatine deiminase gene expression and stress tolerance. J Bacteriol 191:7363–7366 10.1128/JB.01054-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Lemme A, Sztajer H, Wagner-Döbler I. 2010. Characterization of mleR, a positive regulator of malolactic fermentation and part of the acid tolerance response in Streptococcus mutans. BMC Microbiol 10:58 10.1186/1471-2180-10-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Sheng J, Marquis RE. 2007. Malolactic fermentation by Streptococcus mutans. FEMS Microbiol Lett 272:196–201 10.1111/j.1574-6968.2007.00744.x. [DOI] [PubMed] [Google Scholar]
  • 83.Marquis RE. 1995. Oxygen metabolism, oxidative stress and acid-base physiology of dental plaque biofilms. J Ind Microbiol 15:198–207 10.1007/BF01569826. [DOI] [PubMed] [Google Scholar]
  • 84.Imlay JA. 2013. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol 11:443–454 10.1038/nrmicro3032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Kajfasz JK, Ganguly T, Hardin EL, Abranches J, Lemos JA. 2017. Transcriptome responses of Streptococcus mutans to peroxide stress: identification of novel antioxidant pathways regulated by Spx. Sci Rep 7:16018 10.1038/s41598-017-16367-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Galvão LC, Miller JH, Kajfasz JK, Scott-Anne K, Freires IA, Franco GC, Abranches J, Rosalen PL, Lemos JA. 2015. Transcriptional and phenotypic characterization of novel Spx-regulated genes in Streptococcus mutans. PLoS One 10:e0124969 10.1371/journal.pone.0124969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Yamamoto Y, Fukui K, Koujin N, Ohya H, Kimura K, Kamio Y. 2004. Regulation of the intracellular free iron pool by Dpr provides oxygen tolerance to Streptococcus mutans. J Bacteriol 186:5997–6002 10.1128/JB.186.18.5997-6002.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Kajfasz JK, Rivera-Ramos I, Scott-Anne K, Gregoire S, Abranches J, Lemos JA. 2015. Transcription of oxidative stress genes is directly activated by SpxA1 and, to a lesser extent, by SpxA2 in Streptococcus mutans. J Bacteriol 197:2160–2170 10.1128/JB.00118-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Galvão LC, Rosalen PL, Rivera-Ramos I, Franco GC, Kajfasz JK, Abranches J, Bueno-Silva B, Koo H, Lemos JA. 2017. Inactivation of the spxA1 or spxA2 gene of Streptococcus mutans decreases virulence in the rat caries model. Mol Oral Microbiol 32:142–153 10.1111/omi.12160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Kajfasz JK, Rivera-Ramos I, Abranches J, Martinez AR, Rosalen PL, Derr AM, Quivey RG, Lemos JA. 2010. Two Spx proteins modulate stress tolerance, survival, and virulence in Streptococcus mutans. J Bacteriol 192:2546–2556 10.1128/JB.00028-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Stock AM, Robinson VL, Goudreau PN. 2000. Two-component signal transduction. Annu Rev Biochem 69:183–215 10.1146/annurev.biochem.69.1.183. [DOI] [PubMed] [Google Scholar]
  • 92.Smith EG, Spatafora GA. 2012. Gene regulation in S. mutans: complex control in a complex environment. J Dent Res 91:133–141 10.1177/0022034511415415. [DOI] [PubMed] [Google Scholar]
  • 93.Senadheera D, Krastel K, Mair R, Persadmehr A, Abranches J, Burne RA, Cvitkovitch DG. 2009. Inactivation of VicK affects acid production and acid survival of Streptococcus mutans. J Bacteriol 191:6415–6424 10.1128/JB.00793-09. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Senadheera MD, Lee AW, Hung DC, Spatafora GA, Goodman SD, Cvitkovitch DG. 2007. The Streptococcus mutans vicX gene product modulates gtfB/C expression, biofilm formation, genetic competence, and oxidative stress tolerance. J Bacteriol 189:1451–1458 10.1128/JB.01161-06. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Perry JA, Jones MB, Peterson SN, Cvitkovitch DG, Lévesque CM. 2009. Peptide alarmone signalling triggers an auto-active bacteriocin necessary for genetic competence. Mol Microbiol 72:905–917 10.1111/j.1365-2958.2009.06693.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Tremblay YD, Lo H, Li YH, Halperin SA, Lee SF. 2009. Expression of the Streptococcus mutans essential two-component regulatory system VicRK is pH and growth-phase dependent and controlled by the LiaFSR three-component regulatory system. Microbiology 155:2856–2865 10.1099/mic.0.028456-0. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 97.Chong P, Drake L, Biswas I. 2008. LiaS regulates virulence factor expression in Streptococcus mutans. Infect Immun 76:3093–3099 10.1128/IAI.01627-07. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Shankar M, Mohapatra SS, Biswas S, Biswas I. 2015. Gene regulation by the LiaSR two-component system in Streptococcus mutans. PLoS One 10:e0128083 10.1371/journal.pone.0128083. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Biswas S, Biswas I. 2006. Regulation of the glucosyltransferase (gtfBC) operon by CovR in Streptococcus mutans. J Bacteriol 188:988–998 10.1128/JB.188.3.988-998.2006. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Duque C, Stipp RN, Wang B, Smith DJ, Höfling JF, Kuramitsu HK, Duncan MJ, Mattos-Graner RO. 2011. Downregulation of GbpB, a component of the VicRK regulon, affects biofilm formation and cell surface characteristics of Streptococcus mutans. Infect Immun 79:786–796 10.1128/IAI.00725-10. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Stipp RN, Boisvert H, Smith DJ, Höfling JF, Duncan MJ, Mattos-Graner RO. 2013. CovR and VicRK regulate cell surface biogenesis genes required for biofilm formation in Streptococcus mutans. PLoS One 8:e58271 10.1371/journal.pone.0058271. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Lyon GJ, Novick RP. 2004. Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 25:1389–1403 10.1016/j.peptides.2003.11.026. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 103.Monnet V, Juillard V, Gardan R. 2016. Peptide conversations in Gram-positive bacteria. Crit Rev Microbiol 42:339–351. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 104.Shanker E, Federle MJ. 2017. Quorum sensing regulation of competence and bacteriocins in Streptococcus pneumoniae and mutans. Genes (Basel) 8:E15 10.3390/genes8010015. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Hamada S, Ooshima T. 1975. Inhibitory spectrum of a bacteriocinlike substance (mutacin) produced by some strains of Streptococcus mutans. J Dent Res 54:140–145 10.1177/00220345750540010801. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 106.Kreth J, Merritt J, Shi W, Qi F. 2005. Co-ordinated bacteriocin production and competence development: a possible mechanism for taking up DNA from neighbouring species. Mol Microbiol 57:392–404 10.1111/j.1365-2958.2005.04695.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Yonezawa H, Kuramitsu HK. 2005. Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5. Antimicrob Agents Chemother 49:541–548 10.1128/AAC.49.2.541-548.2005. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Hossain MS, Biswas I. 2012. An extracelluar protease, SepM, generates functional competence-stimulating peptide in Streptococcus mutans UA159. J Bacteriol 194:5886–5896 10.1128/JB.01381-12. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Martin B, Quentin Y, Fichant G, Claverys JP. 2006. Independent evolution of competence regulatory cascades in streptococci? Trends Microbiol 14:339–345 10.1016/j.tim.2006.06.007. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 110.Kreth J, Hung DC, Merritt J, Perry J, Zhu L, Goodman SD, Cvitkovitch DG, Shi W, Qi F. 2007. The response regulator ComE in Streptococcus mutans functions both as a transcription activator of mutacin production and repressor of CSP biosynthesis. Microbiology 153:1799–1807 10.1099/mic.0.2007/005975-0. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Kreth J, Merritt J, Zhu L, Shi W, Qi F. 2006. Cell density- and ComE-dependent expression of a group of mutacin and mutacin-like genes in Streptococcus mutans. FEMS Microbiol Lett 265:11–17 10.1111/j.1574-6968.2006.00459.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 112.Ahn SJ, Wen ZT, Burne RA. 2006. Multilevel control of competence development and stress tolerance in Streptococcus mutans UA159. Infect Immun 74:1631–1642 10.1128/IAI.74.3.1631-1642.2006. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Hale JD, Ting YT, Jack RW, Tagg JR, Heng NC. 2005. Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: elucidation of the antimicrobial repertoire by genetic dissection. Appl Environ Microbiol 71:7613–7617 10.1128/AEM.71.11.7613-7617.2005. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Mashburn-Warren L, Morrison DA, Federle MJ. 2010. A novel double-tryptophan peptide pheromone controls competence in Streptococcus spp. via an Rgg regulator. Mol Microbiol 78:589–606 10.1111/j.1365-2958.2010.07361.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Khan R, Rukke HV, Ricomini Filho AP, Fimland G, Arntzen MO, Thiede B, Petersen FC. 2012. Extracellular identification of a processed type II ComR/ComS pheromone of Streptococcus mutans. J Bacteriol 194:3781–3788 10.1128/JB.00624-12. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Merritt J, Qi F. 2012. The mutacins of Streptococcus mutans: regulation and ecology. Mol Oral Microbiol 27:57–69 10.1111/j.2041-1014.2011.00634.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Kamiya RU, Taiete T, Gonçalves RB. 2011. Mutacins of Streptococcus mutans. Braz J Microbiol 42:1248–1258 10.1590/S1517-83822011000400001. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Kreth J, Merritt J, Shi W, Qi F. 2005. Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol 187:7193–7203 10.1128/JB.187.21.7193-7203.2005. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Okinaga T, Xie Z, Niu G, Qi F, Merritt J. 2010. Examination of the hdrRM regulon yields insight into the competence system of Streptococcus mutans. Mol Oral Microbiol 25:165–177 10.1111/j.2041-1014.2010.00574.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 120.Okinaga T, Niu G, Xie Z, Qi F, Merritt J. 2010. The hdrRM operon of Streptococcus mutans encodes a novel regulatory system for coordinated competence development and bacteriocin production. J Bacteriol 192:1844–1852 10.1128/JB.01667-09. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Aspiras MB, Ellen RP, Cvitkovitch DG. 2004. ComX activity of Streptococcus mutans growing in biofilms. FEMS Microbiol Lett 238:167–174. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 122.Chen X, Schauder S, Potier N, Van Dorsselaer A, Pelczer I, Bassler BL, Hughson FM. 2002. Structural identification of a bacterial quorum-sensing signal containing boron. Nature 415:545–549 10.1038/415545a. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 123.Merritt J, Kreth J, Shi W, Qi F. 2005. LuxS controls bacteriocin production in Streptococcus mutans through a novel regulatory component. Mol Microbiol 57:960–969 10.1111/j.1365-2958.2005.04733.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 124.Wen ZT, Nguyen AH, Bitoun JP, Abranches J, Baker HV, Burne RA. 2011. Transcriptome analysis of LuxS-deficient Streptococcus mutans grown in biofilms. Mol Oral Microbiol 26:2–18 10.1111/j.2041-1014.2010.00581.x. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Sztajer H, Lemme A, Vilchez R, Schulz S, Geffers R, Yip CY, Levesque CM, Cvitkovitch DG, Wagner-Döbler I. 2008. Autoinducer-2-regulated genes in Streptococcus mutans UA159 and global metabolic effect of the luxS mutation. J Bacteriol 190:401–415 10.1128/JB.01086-07. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Seaton K, Ahn SJ, Sagstetter AM, Burne RA. 2011. A transcriptional regulator and ABC transporters link stress tolerance, (p)ppGpp, and genetic competence in Streptococcus mutans. J Bacteriol 193:862–874 10.1128/JB.01257-10. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Lemos JA, Brown TA Jr, Burne RA. 2004. Effects of RelA on key virulence properties of planktonic and biofilm populations of Streptococcus mutans. Infect Immun 72:1431–1440 10.1128/IAI.72.3.1431-1440.2004. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Peng X, Zhang Y, Bai G, Zhou X, Wu H. 2016. Cyclic di-AMP mediates biofilm formation. Mol Microbiol 99:945–959 10.1111/mmi.13277. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Gaca AO, Colomer-Winter C, Lemos JA. 2015. Many means to a common end: the intricacies of (p)ppGpp metabolism and its control of bacterial homeostasis. J Bacteriol 197:1146–1156 10.1128/JB.02577-14. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Lemos JA, Lin VK, Nascimento MM, Abranches J, Burne RA. 2007. Three gene products govern (p)ppGpp production by Streptococcus mutans. Mol Microbiol 65:1568–1581 10.1111/j.1365-2958.2007.05897.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 131.Kaspar J, Kim JN, Ahn SJ, Burne RA. 2016. An essential role for (p)ppGpp in the integration of stress tolerance, peptide signaling, and competence development in Streptococcus mutans. Front Microbiol 7:1162 10.3389/fmicb.2016.01162. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Commichau FM, Dickmanns A, Gundlach J, Ficner R, Stülke J. 2015. A jack of all trades: the multiple roles of the unique essential second messenger cyclic di-AMP. Mol Microbiol 97:189–204 10.1111/mmi.13026. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 133.Giacaman RA, Torres S, Gómez Y, Muñoz-Sandoval C, Kreth J. 2015. Correlation of Streptococcus mutans and Streptococcus sanguinis colonization and ex vivo hydrogen peroxide production in carious lesion-free and high caries adults. Arch Oral Biol 60:154–159 10.1016/j.archoralbio.2014.09.007. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 134.Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. 2010. The human oral microbiome. J Bacteriol 192:5002–5017 10.1128/JB.00542-10. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Luppens SB, Kara D, Bandounas L, Jonker MJ, Wittink FR, Bruning O, Breit TM, Ten Cate JM, Crielaard W. 2008. Effect of Veillonella parvula on the antimicrobial resistance and gene expression of Streptococcus mutans grown in a dual-species biofilm. Oral Microbiol Immunol 23:183–189 10.1111/j.1399-302X.2007.00409.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 136.Kara D, Luppens SB, van Marle J, Ozok R, ten Cate JM. 2007. Microstructural differences between single-species and dual-species biofilms of Streptococcus mutans and Veillonella parvula, before and after exposure to chlorhexidine. FEMS Microbiol Lett 271:90–97 10.1111/j.1574-6968.2007.00701.x. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 137.Liu J, Wu C, Huang IH, Merritt J, Qi F. 2011. Differential response of Streptococcus mutans towards friend and foe in mixed-species cultures. Microbiology 157:2433–2444 10.1099/mic.0.048314-0. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.de Carvalho FG, Silva DS, Hebling J, Spolidorio LC, Spolidorio DM. 2006. Presence of mutans streptococci and Candida spp. in dental plaque/dentine of carious teeth and early childhood caries. Arch Oral Biol 51:1024–1028 10.1016/j.archoralbio.2006.06.001. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 139.Gregoire S, Xiao J, Silva BB, Gonzalez I, Agidi PS, Klein MI, Ambatipudi KS, Rosalen PL, Bauserman R, Waugh RE, Koo H. 2011. Role of glucosyltransferase B in interactions of Candida albicans with Streptococcus mutans and with an experimental pellicle on hydroxyapatite surfaces. Appl Environ Microbiol 77:6357–6367 10.1128/AEM.05203-11. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Falsetta ML, Klein MI, Colonne PM, Scott-Anne K, Gregoire S, Pai CH, Gonzalez-Begne M, Watson G, Krysan DJ, Bowen WH, Koo H. 2014. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect Immun 82:1968–1981 10.1128/IAI.00087-14. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Lemos JA, Quivey RG Jr, Koo H, Abranches J. 2013. Streptococcus mutans: a new Gram-positive paradigm? Microbiology 159:436–445 10.1099/mic.0.066134-0. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Hasona A, Crowley PJ, Levesque CM, Mair RW, Cvitkovitch DG, Bleiweis AS, Brady LJ. 2005. Streptococcal viability and diminished stress tolerance in mutants lacking the signal recognition particle pathway or YidC2. Proc Natl Acad Sci U S A 102:17466–17471 10.1073/pnas.0508778102. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Williams ML, Crowley PJ, Hasona A, Brady LJ. 2014. YlxM is a newly identified accessory protein that influences the function of signal recognition particle pathway components in Streptococcus mutans. J Bacteriol 196:2043–2052 10.1128/JB.01465-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Bowen WH. 2016. Dental caries: not just holes in teeth! A perspective. Mol Oral Microbiol 31:228–233 10.1111/omi.12132. [DOI] [PubMed] [Google Scholar]
  • 145.Batista MT, Ferreira EL, Pereira GS, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LCS, Ferreira RCC. 2017. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine 35:7273–7282 10.1016/j.vaccine.2017.11.007. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 146.Cao XX, Li YH, Ye QL, Hu X, Wang TF, Fan MW. 2017. Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents. Hum Vaccin Immunother 13:2332–2340 10.1080/21645515.2017.1349046. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 147.Yan YH, Yu F, Zeng C, Cao LH, Zhang Z, Xu QA. 2016. CCL17 combined with CCL19 as a nasal adjuvant enhances the immunogenicity of an anti-caries DNA vaccine in rodents. Acta Pharmacol Sin 37:1229–1236 10.1038/aps.2016.73. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Yang J, Sun Y, Bao R, Zhou D, Yang Y, Cao Y, Yu J, Zhao B, Li Y, Yan H, Zhong M. 2017. Second-generation flagellin-rPAc fusion protein, KFD2-rPAc, shows high protective efficacy against dental caries with low potential side effects. Sci Rep 7:11191 10.1038/s41598-017-10247-8. [PubMed] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Santiago KB, Piana GM, Conti BJ, Cardoso EO, Murbach Teles Andrade BF, Zanutto MR, Mores Rall VL, Fernandes A Jr, Sforcin JM. 2017. Microbiological control and antibacterial action of a propolis-containing mouthwash and control of dental plaque in humans. Nat Prod Res 32:1441–1445. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 150.Lee HJ, Kang SM, Jeong SH, Chung KH, Kim BI. 2017. Antibacterial photodynamic therapy with curcumin and Curcuma xanthorrhiza extract against Streptococcus mutans. Photodiagn Photodyn Ther 20:116–119 10.1016/j.pdpdt.2017.09.003. [PubMed] [DOI] [PubMed] [Google Scholar]
  • 151.Koo H, Duarte S, Murata RM, Scott-Anne K, Gregoire S, Watson GE, Singh AP, Vorsa N. 2010. Influence of cranberry proanthocyanidins on formation of biofilms by Streptococcus mutans on saliva-coated apatitic surface and on dental caries development in vivo. Caries Res 44:116–126 10.1159/000296306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Xu X, Zhou XD, Wu CD. 2011. The tea catechin epigallocatechin gallate suppresses cariogenic virulence factors of Streptococcus mutans. Antimicrob Agents Chemother 55:1229–1236 10.1128/AAC.01016-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Eckert R, He J, Yarbrough DK, Qi F, Anderson MH, Shi W. 2006. Targeted killing of Streptococcus mutans by a pheromone-guided “smart” antimicrobial peptide. Antimicrob Agents Chemother 50:3651–3657 10.1128/AAC.00622-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Guo L, McLean JS, Yang Y, Eckert R, Kaplan CW, Kyme P, Sheikh O, Varnum B, Lux R, Shi W, He X. 2015. Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology. Proc Natl Acad Sci U S A 112:7569–7574 10.1073/pnas.1506207112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Eckert R, Sullivan R, Shi W. 2012. Targeted antimicrobial treatment to re-establish a healthy microbial flora for long-term protection. Adv Dent Res 24:94–97 10.1177/0022034512453725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Garcia SS, Blackledge MS, Michalek S, Su L, Ptacek T, Eipers P, Morrow C, Lefkowitz EJ, Melander C, Wu H. 2017. Targeting of Streptococcus mutans biofilms by a novel small molecule prevents dental caries and preserves the oral microbiome. J Dent Res 96:807–814 10.1177/0022034517698096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Burne RA, Marquis RE. 2000. Alkali production by oral bacteria and protection against dental caries. FEMS Microbiol Lett 193:1–6 10.1111/j.1574-6968.2000.tb09393.x. [DOI] [PubMed] [Google Scholar]
  • 158.Huang X, Palmer SR, Ahn SJ, Richards VP, Williams ML, Nascimento MM, Burne RA. 2016. A highly arginolytic Streptococcus species that potently antagonizes Streptococcus mutans. Appl Environ Microbiol 82:2187–2201 10.1128/AEM.03887-15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Microbiology Spectrum are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES